Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Mar 30, 2020 9:48 PM EDT Latest News March 30, 2020 Gilead Announces Expiration of Hart-Scott-Rodino Waiting Period for Forty Seven Tender Offer March 19, 2020 U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection March 11, 2020 New Clinical Study Data for Gilead’s Investigational HIV-1 Capsid Inhibitor GS-6207 Presented at CROI 2020 View All Events May 6, 2020 at 10:00 AM PDT Gilead Sciences 2020 Stockholders Meeting Mar 2, 2020 at 12:00 PM EST Gilead Sciences at the Cowen 40th Annual Health Care Conference Mar 2, 2020 at 8:00 AM EST Gilead Sciences Conference Call View All
